BOTHELL, Wash., March 13, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback